Could cause temporary or reversible harm; serious harm is unlikely.
Superpotent and Subpotent
| Brand name | ISOTRETINOIN |
| Generic name | ISOTRETINOIN |
| Active ingredient(s) | ISOTRETINOIN |
| Distributed by / for | Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 |
| NDC | 0591-2435-15 |
| Full product label | Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2435-15 (carton), NDC 0591-2435-45 (blister pack). |
| Recalling firm | Teva Pharmaceuticals USA, Inc |
| Distribution | FL, OH, PR & MS |
| Quantity | 21984 packages |
| Recall initiated | 2026-01-12 |
| Report date | 2026-04-15 |
| Recall completed | — |
| Recall number | D-0445-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗